By Vistaar

Published in: Vistaar

Published on: February 26, 2020

Introductory Paragraph: ANVISA published the Resolution RDC 318/2019, which details about the criteria for carrying out stability studies of active pharmaceutical ingredients (IFAs), and of new, innovative, generic, similar, streamlined, specific drugs, with simplified notification, herbal and radiopharmaceuticals.

(Also linked Regulatory Information)

Advance Stability Knowledge

Would you like to see a particular publication, guidance, organization, supplier, event, or career opportunity on StabilityHub? Contact us with your suggestion!